Application no. and date | 06750845.7 (espacenet) (Federated) (European Patent Register), 20060420 | Patent/reg. no. and date | DK/EP 1885373, 20150520 | Publication date | 20080213 | Priority no. and date | US 674946 P, 20050425 | EP pub. no. and date |
EP 1885373 20080213 | Effective date | | Applicant/owner | Dow Pharmaceutical Sciences, 1330A Redwood Way
Petaluma, CA 94954-6542, US, Dermalogix Partners, Inc., 672 US Route 1 PO Box 1510
Scarborough, ME 04070, US | Applicant ref. no. | T5029DK00 | Inventor | DOW, Gordon, J., 4189 Chaparrel Court
Santa Rosa, California 95409, US, STEWART, Daniel, M., 495 Dunston
Bloomfield Hills, Michigan 48304, US | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | Opponent | | IPC Class | A61K 31/045 (2006.01) , A61K 31/56 (2006.01) , A61K 31/573 (2006.01) , A61K 47/14 (2006.01) , A61L 9/04 (2006.01) , A61P 17/06 (2006.01) | Title | Anvendelse af en sprayformulering af clobetasol til behandling af psoriasis | Int. application no. | US2006014903 | Int. publication no. | WO2006115987 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|